Michel Lagarde - 07 May 2021 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Executive Vice President
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Issuer symbol
TMO
Transactions as of
07 May 2021
Net transactions value
-$16,518,242
Form type
4
Filing time
11 May 2021, 16:44:02 UTC
Next filing
24 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $5,546,169 +29,100 +124% $190.59 52,629 07 May 2021 Direct
transaction TMO Common Stock Sale $3,591,256 -7,662 -15% $468.71 44,967 07 May 2021 Direct F1
transaction TMO Common Stock Sale $2,613,627 -5,566 -12% $469.57 39,401 07 May 2021 Direct F2
transaction TMO Common Stock Sale $1,387,416 -2,949 -7.5% $470.47 36,452 07 May 2021 Direct F3
transaction TMO Common Stock Sale $518,980 -1,100 -3% $471.80 35,352 07 May 2021 Direct F4
transaction TMO Common Stock Sale $720,059 -1,523 -4.3% $472.79 33,829 07 May 2021 Direct F5
transaction TMO Common Stock Sale $1,221,972 -2,578 -7.6% $474.00 31,251 07 May 2021 Direct F6
transaction TMO Common Stock Sale $1,626,468 -3,424 -11% $475.02 27,827 07 May 2021 Direct F7
transaction TMO Common Stock Sale $1,809,600 -3,802 -14% $475.96 24,025 07 May 2021 Direct F8
transaction TMO Common Stock Sale $604,582 -1,268 -5.3% $476.80 22,757 07 May 2021 Direct F9
transaction TMO Common Stock Sale $1,989,519 -4,162 -18% $478.02 18,595 07 May 2021 Direct F10
transaction TMO Common Stock Sale $64,157 -134 -0.72% $478.78 18,461 07 May 2021 Direct F11
transaction TMO Common Stock Options Exercise $4,116,744 +21,600 +117% $190.59 40,061 10 May 2021 Direct
transaction TMO Common Stock Sale $3,362,659 -7,259 -18% $463.24 32,802 10 May 2021 Direct F12
transaction TMO Common Stock Sale $1,732,016 -3,734 -11% $463.85 29,068 10 May 2021 Direct F13
transaction TMO Common Stock Sale $2,349,069 -5,051 -17% $465.07 24,017 10 May 2021 Direct F14
transaction TMO Common Stock Sale $2,378,151 -5,103 -21% $466.03 18,914 10 May 2021 Direct F15
transaction TMO Common Stock Sale $211,623 -453 -2.4% $467.16 18,461 10 May 2021 Direct F16

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -29,100 -100% $0.000000* 0 07 May 2021 Common Stock 29,100 $190.59 Direct
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -21,600 -59% $0.000000 14,900 10 May 2021 Common Stock 21,600 $190.59 Direct F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $468.08 to $469.07, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), and (16) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $469.08 to $470.05, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $470.11 to $470.96, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $471.14 to $472.015, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $472.305 to $473.06, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $473.35 to $474.33, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $474.38 to $475.37, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $475.38 to $476.37, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $476.43 to $477.37, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $477.56 to $478.55, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $478.56 to $478.85, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $462.57 to $463.56, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $463.57 to $464.52, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $464.59 to $465.54, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $465.59 to $466.54, inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $466.99 to $467.37, inclusive.
F17 The option vests in four equal annual installments. One-quarter of the shares vested on September 7, 2018, 2019 and 2020, and the remaining one-quarter will vest on September 7, 2021.